Molecular Human Reproduction, Vol. 6, No. 11, 1013-1018,
November 2000
© 2000 European Society of Human Reproduction and Embryology
Uterine physiology |
Expression of sex steroid receptors and Ki-67 in the endometria of menorrhagic women: effects of intrauterine levonorgestrel
1 Department of Obstetrics and Gynaecology, Helsinki University Central Hospital, PO Box 140, 00029 HUCH and 2 Health Services Research Unit, STAKES, Siltasaarenkatu 18, 00531 Helsinki, Finland
Abstract
The levonorgestrel-releasing intrauterine system (LNG-IUS) has proven to be the most effective medical treatment in reducing the amount of menstrual blood loss. However, the molecular mechanisms underlying menorrhagia and/or accounting for the therapeutic effect of the LNG-IUS are still obscure. In this study, we used immunohistochemistry to compare the distribution of sex steroid receptors and the proliferation marker Ki-67 in the endometria of women with and without menorrhagia before and after 6 and 12 months of treatment with an LNG-IUS. The study sample included 67 women (aged 35–49 years) who had spontaneous ovulatory cycles. In women with menorrhagia, secretory phase endometrium exhibited more proliferative activity than in women without menorrhagia. No significant differences were found in the immunoreactivity of the oestrogen or progesterone receptors in women either with or without menorrhagia suggesting that, in addition to endocrine hormones, other factors are involved in the regulation of endometrial proliferation and menstrual blood loss. A total of 35 women were treated with LNG-IUS. After 6 months use of an LNG-IUS, the immunoreactivity of both epithelial and stromal progesterone receptors, as well as those of epithelial Ki-67 declined, and no differences were detectable between the women in the menorrhagia and control groups. Breakthrough bleeding remained a problem for nine (26%) LNG-IUS users, with no association with the pre-treatment amount of bleeding. No significant differences were found in the parameters studied between the women with and without breakthrough bleeding 6 months after insertion of an LNG-IUS.
endometrium/Ki-67/levonorgestrel-releasing IUS/menorrhagia/sex steroid receptors
Notes
3 To whom correspondence should be addressed at: Siltasaarenkatu 18, 00531 Helsinki, Finland. E-mail: Ritva.Hurskainen{at}stakes.fi
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  O. Heikinheimo, S. Vani, O. Carpen, A. Tapper, P. Harkki, E.-M. Rutanen, and H. Critchley Intrauterine release of progesterone antagonist ZK230211 is feasible and results in novel endometrial effects: a pilot study Hum. Reprod., September 1, 2007; 22(9): 2515 - 2522. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. K. Hejmadi, S. Chaudhri, R. Ganesan, and T. P. Rollason Morphologic Changes in the Endometrium Associated With the Use of the Mirena Coil: A Retrospective Study of 106 Cases International Journal of Surgical Pathology, April 1, 2007; 15(2): 148 - 154. [Abstract] [PDF]
|
|
|
|
|
|
F. B. Lockhat, J. O. Emembolu, and J. C. Konje The efficacy, side-effects and continuation rates in women with symptomatic endometriosis undergoing treatment with an intra-uterine administered progestogen (levonorgestrel): a 3 year follow-up Hum. Reprod., March 1, 2005; 20(3): 789 - 793. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B.A. Roopa, A. Loganath, and K. Singh The effect of a levonorgestrel-releasing intrauterine system on angiogenic growth factors in the endometrium Hum. Reprod., September 1, 2003; 18(9): 1809 - 1819. [Abstract] [Full Text] [PDF]
|
|